Literature DB >> 21504714

Identification of the TAF15-ZNF384 fusion gene in two new cases of acute lymphoblastic leukemia with a t(12;17)(p13;q12).

Kaja Beate Nyquist1, Jim Thorsen, Bernward Zeller, Alf Haaland, Gunhild Trøen, Sverre Heim, Francesca Micci.   

Abstract

We report the clinical, cytogenetic, and molecular data of two patients diagnosed with acute lymphoblastic leukemia characterized by the rare translocation t(12;17)(p13;q12). This translocation has been reported in 25 cases and its putative molecular consequence, the formation of a TAF15-ZNF384 fusion gene, in only six cases. We used fluorescence in situ hybridization followed by long-range polymerase chain reaction to find the translocation breakpoints. A fusion between TAF15 and ZNF384 was identified and confirmed by nucleotide sequencing. Our results confirm that the t(12;17)(p13;q12) leading to a TAF15-ZNF384 fusion gene characterizes a specific subgroup of acute lymphoblastic leukemia and suggest that two different breakpoints in TAF15 may be involved. Whether the two variants of the TAF15-ZNF384 fusion that these correspond to are in any way hematologically or prognostically different, is unknown.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21504714     DOI: 10.1016/j.cancergen.2011.01.003

Source DB:  PubMed          Journal:  Cancer Genet


  12 in total

1.  ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype.

Authors:  Shinsuke Hirabayashi; Kentaro Ohki; Kazuhiko Nakabayashi; Hitoshi Ichikawa; Yukihide Momozawa; Kohji Okamura; Akinori Yaguchi; Kazuki Terada; Yuya Saito; Ai Yoshimi; Hiroko Ogata-Kawata; Hiromi Sakamoto; Motohiro Kato; Junya Fujimura; Moeko Hino; Akitoshi Kinoshita; Harumi Kakuda; Hidemitsu Kurosawa; Keisuke Kato; Ryosuke Kajiwara; Koichi Moriwaki; Tsuyoshi Morimoto; Kozue Nakamura; Yasushi Noguchi; Tomoo Osumi; Kazuo Sakashita; Junko Takita; Yuki Yuza; Koich Matsuda; Teruhiko Yoshida; Kenji Matsumoto; Kenichiro Hata; Michiaki Kubo; Yoichi Matsubara; Takashi Fukushima; Katsuyoshi Koh; Atsushi Manabe; Akira Ohara; Nobutaka Kiyokawa
Journal:  Haematologica       Date:  2016-09-15       Impact factor: 9.941

Review 2.  An Adult Patient with Early Pre-B Acute Lymphoblastic Leukemia with t(12;17)(p13;q21)/ZNF384-TAF15.

Authors:  Nikolaos Georgakopoulos; Panagiotis Diamantopoulos; Francesca Micci; Nefeli Giannakopoulou; Konstantinos Zervakis; Aglaia Dimitrakopoulou; Nora-Athina Viniou
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

3.  Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?

Authors:  Thale Kristin Olsen; Ioannis Panagopoulos; Torstein R Meling; Francesca Micci; Ludmila Gorunova; Jim Thorsen; Bernt Due-Tønnessen; David Scheie; Marius Lund-Iversen; Bård Krossnes; Cathrine Saxhaug; Sverre Heim; Petter Brandal
Journal:  Neuro Oncol       Date:  2015-03-19       Impact factor: 12.300

4.  New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: cancer and leukemia group B 8461.

Authors:  Alison Walker; Krzysztof Mrózek; Jessica Kohlschmidt; Kathleen W Rao; Mark J Pettenati; Lisa J Sterling; Guido Marcucci; Andrew J Carroll; Clara D Bloomfield
Journal:  Genes Chromosomes Cancer       Date:  2012-12-10       Impact factor: 5.006

5.  Transcriptome sequencing in pediatric acute lymphoblastic leukemia identifies fusion genes associated with distinct DNA methylation profiles.

Authors:  Yanara Marincevic-Zuniga; Johan Dahlberg; Sara Nilsson; Amanda Raine; Sara Nystedt; Carl Mårten Lindqvist; Eva C Berglund; Jonas Abrahamsson; Lucia Cavelier; Erik Forestier; Mats Heyman; Gudmar Lönnerholm; Jessica Nordlund; Ann-Christine Syvänen
Journal:  J Hematol Oncol       Date:  2017-08-14       Impact factor: 17.388

6.  Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.

Authors:  Maoxiang Qian; Hui Zhang; Shirley Kow-Yin Kham; Shuguang Liu; Chuang Jiang; Xujie Zhao; Yi Lu; Charnise Goodings; Ting-Nien Lin; Ranran Zhang; Takaya Moriyama; Zhaohong Yin; Zhenhua Li; Thuan Chong Quah; Hany Ariffin; Ah Moy Tan; Shuhong Shen; Deepa Bhojwani; Shaoyan Hu; Suning Chen; Huyong Zheng; Ching-Hon Pui; Allen Eng-Juh Yeoh; Jun J Yang
Journal:  Genome Res       Date:  2016-11-30       Impact factor: 9.043

7.  Whole-transcriptome sequencing identifies novel IRF2BP2-CDX1 fusion gene brought about by translocation t(1;5)(q42;q32) in mesenchymal chondrosarcoma.

Authors:  Kaja B Nyquist; Ioannis Panagopoulos; Jim Thorsen; Lisbeth Haugom; Ludmila Gorunova; Bodil Bjerkehagen; Alexander Fosså; Marianne Guriby; Torfinn Nome; Ragnhild A Lothe; Rolf I Skotheim; Sverre Heim; Francesca Micci
Journal:  PLoS One       Date:  2012-11-21       Impact factor: 3.240

8.  RNA polymerase III transcriptomes in human embryonic stem cells and induced pluripotent stem cells, and relationships with pluripotency transcription factors.

Authors:  Ravi K Alla; Bradley R Cairns
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

9.  t(12;17)(p13;q12)/TAF15-ZNF384 Rearrangement in Acute Lymphoblastic Leukemia.

Authors:  Jieun Kim; Hyo Sun Kim; Saeam Shin; Seung Tae Lee; Jong Rak Choi
Journal:  Ann Lab Med       Date:  2016-07       Impact factor: 3.464

10.  EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.

Authors:  Akifumi Endo; Daisuke Tomizawa; Yuki Aoki; Tomohiro Morio; Shuki Mizutani; Masatoshi Takagi
Journal:  Cancer Sci       Date:  2016-11-25       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.